Searched for
NATCO PHARMA USA
Complaint filed against Natco Pharma in US by Fresenius KabiNatco Pharma faces a legal complaint from Fresenius Kabi in the US District Court regarding the marketing of Diazepam injection prefilled s...- Natco Pharma signs pact with MPP to sell Molnupiravir capsulesNatco Pharma has signed a non-exclusive license agreement with the Medicines Patent Pool (MPP), Switzerland to manufacture and sell Molnupi...
- Natco Pharma proposes to acquire Dash PharmaceuticalsAccording to a press release issued by the Hyderabad-based drug maker, Dash is a front-end pharmaceutical sales, marketing and distribution...
- Natco Pharma Q1 results: Net profit declines 39% to Rs 75 crConsolidated total income of the company stood at Rs 427.3 crore for the quarter under consideration. It was Rs 582.1 crore for the same pe...
- Natco Seeks emergency approval to launch Molnupiravir for Covid-19 in IndiaMolnupiravir was originally developed to treat influenza before US-based Merck initiated research to repurpose drug for use against SARS-Co...
- Natco's marketing partner gets USFDA nod for cancer treatment drug"Breckenridge Pharmaceutical Inc (BPI) has received final approval for its abbreviated new drug application (ANDA) for Everolimus tablets f...
- Natco Pharma's marketing partner gets USFDA nod for cancer treatment drug"Breckenridge Pharmaceutical Inc. has received final approval for its abbreviated new drug application (ANDA) for Pomalidomide Capsules fro...
- Why Indian pharma needs more expats on boardsExpats at the helm can help improve corporate governance and transparency
- Natco gets USFDA nod to market renal disease drugNatco's Lanthanum Carbonate strengths are generic equivalent of Shire Development LLC's Fosrenol chewable tablets and are indicated to redu...
- Natco Pharma launches generic blood cancer drug in IndiaNatco has launched pomalidomide capsules in strengths of 1 mg, 2 mg and 4 mg in India.
- Natco Pharma gets USFDA nod for Armodafinil tabletsNatco Pharma has received final approval from the US Food and Drug Administration (USFDA) for generic version of Armodafinil tablets.
- Natco Pharma gets USFDA nod for generic Budesonide capsulesThe company has received "final approval of abbreviated new drug application from the US Food and Drug Administration for generic version o...
- Natco Pharma gets EIR from USFDA for Kothur facilityKothur facility predominantly caters to regulated international markets. EIR is given after the completion of the inspection by the USFDA.
- Gilead to challenge hepatitis C drug patent rejection decision"The main patent applications covering sofosbuvir are still pending before the Indian Patent Office," Alton said.
- Natco pharma's US partner files Abbreviated New Drug Application for EverolimusThe drug, used to prevent organ rejection after a kidney or liver transplant, generated sales of $43.5 mn for the 12-mth period ending July.
- Natco Pharma's partner Mylan Inc files ANDA for generic CopaxoneAccording to IMS health, Copaxone 40 mg/mL had US sales of nearly USD 411.5 million for the 12 months ending June 30, 2014, it added.
- Natco, Mylan to appeal against New York district court verdictThe decision by the US court covers several patents for the chemical composition of Copaxone, methods of using the product and processes fo...
- Over 1 lakh requests pending with patent officesOn the number of applications received and rejected in 2011-12, Scindia said, 43,183 requests have been filed, of which 364 were rejected.
- Natco examining other drugs to identify compulsory license targetsWe have mostly targeted unaffordable life saving drugs which are either unavailable or in-adequately available at an exorbitant cost. These...
- Govt orders recall as Natco cancer drug fails toxin testThe drug regulator (DCGI) acted afer the US firm filed a written complaint citing serious side-effects that the generic may cause.
Load More
